Profile

Yuhui Lin

Founder
Keras360 & The Waterhouse
Japanese: 水の家
Chinese: 红御

About

I am the founder of The Waterhouse 水の家, Singapore. Our journey started as an art editorial platform called NaoRococo.net, bringing together talented individuals from various parts of the world. Over time, we expanded into innovative design and visualization technology.

Keras360, an extension of The Waterhouse, specializes in Art Forensics and provides healthtech data consultancy services through Numerate Associates at keras360.io. Numerate Associates excels in healthcare, data management, drug regulation, medicine adoption, medical affairs, and solutions for life-insurance.

In mid-February 2024, during an examination of hospital workflows, it became apparent that the healthcare system lacks a definitive protocol for healthcare and management enhancements. These could encompass the assessment of patients’ Quality of Life (QoL), the procurement of drugs and medical devices, as well as treatment and diagnostic workflows. A decision was made to commence coding with the fundamental notion that input from each healthcare expert should be collected and anonymized. However, due to security concerns, it became imperative to encrypt all information. Consequently, an encryption protocol was developed, which in turn led to the creation of the 09-tailed fox decrypter integrated with a dedicated Natural Language Processing (NLP) protocol for clinical research. Further details can be found about the i) Keras360 Generation-1 automated 09-tailed Fox decrypter ,and ii) the Delphi-HPE automated encryption data collection.

We have expertise in analyzing data, managing missing data, predictive modeling, and designing clinical trials. In addition, I have worked in scientific publishing and media intelligence. You might find a featured news piece about me at PR Newswire. You can also explore my medical affairs research portfolio at the end of this page or contact ; contact.general@keras360.io.

You may locate my ORCID scientific research profile at: https://orcid.org/0000-0001-6597-1885.

Get in touch

Yuhui is always available for side collaborations and talks worldwide. If you want to chat about statistics, medical drugs, NLPs, Machine Learning, art acquisitions, and wine, or anything else, write to her.

EDUCATION

I completed my undergraduate degree (Hons.) in Biomedical Science at the University of Manchester, UK, from 2005 to 2007, during which I was awarded direct-entry status as a second-year B.Sc. student. Throughout my B.Sc. program, I received a summer research scholarship from the Wellcome Trust in collaboration with the Laboratory of Molecular Biology in Cambridge, UK. Following my graduation, I relocated to London to pursue an M.Sc. in Modern Epidemiology at Imperial College London, completed in 2009 Jan. The preference of academic professors for the combination of Modern and Epidemiology remains unclear; however, it is evident that there has been a significant shift in preventative care and medicine focusing on non-communicable diseases, such as cancer, in contrast to the traditional knowledge on infectious diseases. In February 2011, I moved to Rostock, Germany to join the Max Planck Institute for Demographic Research, where I collaborated with a team of mathematicians and demographers with a specialised interest in human aging rates and the lifetime risk of exposures. My doctoral thesis primarily focused on building mathematical and statistical protocol models for life-saving opportunities, medical interventions, and occupational health, including exposure to cosmic radiation and life expectancy among healthcare practitioners. A portion of my doctoral thesis has been published, as detailed in the section below.

Scientific Publications

Lin, Y., Gajewski, A., & Poznańska, A. (2016). Examining mortality risk and rate of ageing among Polish Olympic athletes: a survival follow-up from 1924 to 2012. BMJ open, 6(4), e010965. doi:10.1136/bmjopen-2015-010965

Lin, Y. (2018). AFT survival model to capture the rate of aging and age-specific mortality trajectories among first-allogeneic hematopoietic stem cells transplant patients. Plos one, 13(3), e0193287. doi:10.1371/journal.pone.0193287

Lin, Y. (2018). The Oddity of Heterogeneity: A Blessing in Disguise. Nature Scientific Reports, 8(1), 10782. doi:10.1038/s41598-018-29081-7

Lin, Y. (2019). 3D Age-Specific Mortality Trajectory: A Survival Analysis Protocol. Springer Nature. Stem Cells and Aging: Methods and Protocols, 311-321. doi:10.1007/7651_2018_189

Lin, Y. (2023). The Lesser Evil: Plutonium-239 or Uranium-235? A Study on F0 Atomic Bomb Survivors. Qeios. doi:10.32388/6GKULJ. (Preprint)

Lin, Y. (2024). The Pandora Box from 12 Countries: Who Benefits More from Modern Interventions?. Qeios. doi:10.32388/JPICV8. (Preprint)

ATTENDENCE

Stanford University, US (2011)
Biodemography Workshop, Conference
PhD student

AXA Conference for Human Longevity, Germany
(2012, 2013)
PhD student

IUSSP, Busan, Korean (2013)
Conference Poster Session
PhD student

MaxNet Aging, Conference for Aging, Germany (2013)
Phd student, Speaker

Max Planck Institute for Demographic Research
Human Aging, Germany (2012, 2013)
Phd student, Speaker

A*Star Symposium Nobel Laureate Sydney Brenner；Singapore (2015)
News Editor

Climate Change COP-20
Marina Bay Sands, Singapore (2015)
News Editor

L’Oreal Women in Science. NUS, Singapore (2015)
News Editor

Suzhou Talent Recruit, China (2016, 2023)
Speaker – The Waterhouse